Page last updated: 2024-09-03

amarogentin and hematoxylin

amarogentin has been researched along with hematoxylin in 1 studies

Compound Research Comparison

Studies
(amarogentin)
Trials
(amarogentin)
Recent Studies (post-2010)
(amarogentin)
Studies
(hematoxylin)
Trials
(hematoxylin)
Recent Studies (post-2010) (hematoxylin)
450352,22825918

Protein Interaction Comparison

ProteinTaxonomyamarogentin (IC50)hematoxylin (IC50)
Chain E, Fibrin beta chainHomo sapiens (human)9.328
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK5317.36
Mcl-1Homo sapiens (human)3.4393
MPI proteinHomo sapiens (human)26.374
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium berghei20.0467
VifHuman immunodeficiency virus 10.46
TatHuman immunodeficiency virus 111.696
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)0.46
large T antigenBetapolyomavirus macacae4.66

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Song, B; Zhou, W1

Other Studies

1 other study(ies) available for amarogentin and hematoxylin

ArticleYear
Amarogentin has protective effects against sepsis-induced brain injury via modulating the AMPK/SIRT1/NF-κB pathway.
    Brain research bulletin, 2022, 10-15, Volume: 189

    Topics: AMP-Activated Protein Kinases; Animals; Brain Injuries; DNA Nucleotidylexotransferase; Eosine Yellowish-(YS); Hematoxylin; Inflammation; Iridoid Glycosides; Iridoids; Lipopolysaccharides; Mice; NF-kappa B; Sepsis; Signal Transduction; Sirtuin 1

2022